Rigel Pharmaceuticals
RIGL
RIGL
152 hedge funds and large institutions have $493M invested in Rigel Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 42 increasing their positions, 54 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
0.2% more ownership
Funds ownership: 8.28% → 8.48% (+0.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 54
Holders
152
Holding in Top 10
1
Calls
$2.2M
Puts
$2.16M
Top Buyers
| 1 | +$16.6M | |
| 2 | +$15.7M | |
| 3 | +$10.8M | |
| 4 |
Millennium Management
New York
|
+$9.06M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$8.68M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$13.1M | |
| 3 | -$10.4M | |
| 4 |
Renaissance Technologies
New York
|
-$6.39M |
| 5 |
Goldman Sachs
New York
|
-$4.43M |